Autologous immunotherapy involves using a patient's own immune cells, such as T-cells, to fight cancer. These cells are modified or expanded outside the body and then reinfused to target and destroy cancer cells. A well-known example is CAR-T cell therapy, which has shown promise in treating certain blood cancers.